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Abstract
Background: Productive thymopoiesis is essential for a robust and healthy immune system. Thymus unfortunately is acutely
sensitive to stress resulting in involution and decreased T cell production. Thymic involution is a complication of many
clinical settings, including infection, malnutrition, starvation, and irradiation or immunosuppressive therapies. Systemic rises
in glucocorticoids and inflammatory cytokines are known to contribute to thymic atrophy. Little is known, however, about
intrathymic mechanisms that may actively contribute to thymus atrophy or initiate thymic recovery following stress events.
Methodology/Principal Findings: Phenotypic, histologic and transcriptome/pathway analysis of murine thymic tissue
during the early stages of endotoxemia-induced thymic involution was performed to identify putative mechanisms that
drive thymic involution during stress. Thymus atrophy in this murine model was confirmed by down-regulation of genes
involved in T cell development, cell activation, and cell cycle progression, correlating with observed phenotypic and
histologic thymus involution. Significant gene changes support the hypothesis that multiple key intrathymic pathways are
differentially activated during stress-induced thymic involution. These included direct activation of thymus tissue by LPS
through TLR signaling, local expression of inflammatory cytokines, inhibition of T cell signaling, and induction of wound
healing/tissue remodeling.
Conclusions/Significance: Taken together, these observations demonstrated that in addition to the classic systemic
response, a direct intrathymic response to endotoxin challenge concurrently contributes to thymic involution during
endotoxemia. These findings are a substantial advancement over current understanding of thymus response to stress and
may lead to the development of novel therapeutic approaches to ameliorate immune deficiency associated with stress
events.
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Introduction
Ongoing and productive thymopoiesis is essential for develop-
ment and maintenance of a robust and healthy immune system.
Many factors have a negative effect on thymopoiesis and acute
thymic atrophy is a complication among a variety of clinical
settings, including bacterial infection [1], starvation [2], and
irradiation or immunosuppressive therapies [3]. In response to
stress, thymus tissue involutes and output of naı ¨ve T cells is
substantially reduced, leaving the host potentially vulnerable to
new infections. The systemic response to stress has been well-
described and involves a rise in glucocorticoids and pro-
inflammatory cytokines; which we and others have shown
negatively impact thymopoiesis and contribute greatly to thymus
atrophy [1,4]. Little is known, however, about intrathymic
mechanisms that may actively drive thymus involution in response
to stress. In contrast to chronic thymic involution associated with
aging, acute stress-induced thymic atrophy can resolve naturally
over time after the stressor is removed [5]. By defining intrathymic
mechanisms driving thymic atrophy and tissue recovery, potential
therapies could be developed to help accelerate thymic recovery
and immune reconstitution.
Endotoxemia-induced acute thymic atrophy is a useful model to
study the impact of acute stress on thymopoiesis [5]. Acute thymic
atrophy in response to endotoxin stress is characterized by specific
loss of CD4+CD8+ double positive (DP) thymocytes and a dramatic
reduction in T cell development [1,6]. Thymic architecture is
severely perturbed following endotoxin challenge, with damage to
thymus epithelium and visible remodeling of thymic morphology,
involving lossof distinctcortico-medullaryjunctions[7,8].Activation
of the hypothalamus-pituitary-adrenal (HPA) axis, resulting in a
systemic rise in glucocorticoids and an acute systemic pro-
inflammatory cytokine cascade, contributes to acute thymic
involution [4]. Important systemic pro-inflammatory cytokines
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[9]. Inflammation activates nuclear factor-kappa B (NF-kB), a
crucial signaling molecule in the immune response [10] and
thymocyte development [11]. While it is clear that these systemic
mechanisms play an important role in stress-induced acute thymic
atrophy [12], underlying intrathymic mechanisms are now also
being appreciated as contributing factors. Previous work from this
laboratory has demonstrated that the IL-6 family member, leukemia
inhibitory factor (LIF), mediates acute thymic atrophy locally by
stimulationofintrathymicpathwaysandsystemicallybyactivation of
the HPA axis [13]. Furthermore, in a model of age-related, chronic
thymic involution, investigators compared rapidly-involuting strains
of mice with slowly-involuting strains of the same age. These studies
identified lowered IL-7 and anti-apoptotic BCL-2, and elevated pro-
apoptotic BAD gene expression levels, as contributors to rapid
involution and disruption of thymopoiesis [14].
These reports support an evolving paradigm of thymus involution,
in which intrathymic mechanisms actively contribute to increased
local inflammation, decreased thymus output, and increased tissue
atrophy. It is therefore hypothesized that intrathymic pathways are
active during endotoxemia-induced acute thymic atrophy leading to
thymopoietic and morphologic dysregulation. A phenotypic, histo-
logic and transcriptome/pathway analysis of murine thymic tissue
during the early stages of endotoxemia-induced involution was
undertaken in this study to define intrathymic mechanisms that drive
acute thymic atrophy. Reported findings support the hypothesis that
multiple key intrathymic pathways are differentially activated during
endotoxemia-induced thymic involution. These include direct
activation of thymus tissue by LPS through TLR signaling, local
expression of inflammatory cytokines, inhibition of T cell signaling,
and induction of wound healing/tissue remodeling.
Results
Acute Thymic Atrophy Induced by Endotoxin Challenge
To demonstrate the effects of endotoxin stress on thymus
homeostasis, 8–10 week old mice were injected intraperitoneally
(IP) with either saline or 100 mg lipopolysaccharide (LPS) and
thymic atrophy was assessed. Thymus weight was unchanged by
LPS one day post treatment, yet was significantly decreased by
LPS three days post challenge (n=10) (Figure 1A). Total thymus
cellularity however was significantly decreased at both one day
and three days post LPS challenge (Figure 1B). A molecular
measurement for TCRa gene rearrangement was employed to
quantify thymopoiesis. Levels of mTREC/mg thymus were
significantly decreased at both one and three days post LPS
challenge (Figure 1C). Thymocyte subset distribution was
significantly altered with LPS treatment after one day, leading to
a specific loss of DP thymocytes by three days (Figure 1D–F).
Changes in thymus architecture were assessed with hematoxylin and
eosin staining of frozen thymus tissue four days post LPS challenge.
Distinct areas of thymus cortex and medulla were visible in thymus
tissue from saline-treated mice (Figure 1G, left panel). In contrast, LPS-
treated mice have lost morphological cortico-medullary distinctions
(Figure 1G, right panel). Taken together, these data indicated that
endotoxemia induces acute thymic atrophy which is detectable at the
cellular level by 24 hours post-challenge and resulted in decreased
cellularity, decreased TCRa gene rearrangement, specific loss of DP
thymocytes, and substantial remodeling of thymic architecture.
Systemic Cytokine Response Induced by Endotoxin
Challenge
A systemic inflammatory cytokine cascade is an important
component of the host response to endotoxin challenge, which
contributes to septic shock and subsequent acute thymic atrophy.
LPS challenge induced peak serum levels (pg/mL) of cytokines
measured at 1, 2, 4, or 6 hr post treatment versus saline controls
(Table 1). Specifically, significant changes were observed in TNFa,
IL-3, IL-10, IL-13, MCP-1, MIP-1b, IL-2, IL-12p40, IL-12p70,
KC, GM-CSF, MIP-1a, RANTES, IL-1a, IL-1b, IL-5, IL-6, IL-
17, Eotaxin and IFN-c. These cytokine levels resolved to baseline
within 12–24 hours (data not shown). Taken together, these data
confirm a potent and significant systemic pro-inflammatory
cytokine cascade in this model, consistent with previous published
work [1,4,13].
Intrathymic Cytokine Gene Expression During Acute
Thymic Atrophy
To investigate if intrathymic production of pro-inflammatory
cytokines was present during thymic atrophy, gene expression
analysis was performed on excised mouse thymus tissue. Many of
the cytokines that were increased significantly in serum after
endotoxin challenge also had significantly increased mRNA level
within thymus tissue (Table 2). These included transcripts for
potent pro-inflammatory cytokines, such as TNFa, IL-12, KC,
MIP-1a, MIP-1b, IL-1a, IL-1b, and IL-6. These observations
suggested that thymic residents actively respond to endotoxin
stress by up-regulating pro-inflammatory cytokine production.
Therefore, further transcriptome analysis was performed to
identify other differentially expressed genes and intrathymic
pathways following endotoxin stress. Microarray analysis revealed
more than 11,000 probe sets with significant changes greater than
1.4 fold one day after LPS challenge (Tables S1 and S2).
Additional filtering was thus used to analyze this large number of
probe sets (i.e. gene ontology and pathway analysis).
Gene Ontology (GO) Analysis of Intrathymic Response to
Endotoxemia-Induced Stress
Transcriptome analysis of whole thymus during the early stages
of acute thymic atrophy revealed significant gene dysregulation
induced by endotoxemia. Significantly modulated intrathymic
genes were grouped into gene ontology categories (GO categories)
based on statistical overrepresentation of GO terms as determined
by a conditional hypergeometric test. Table 3 ranks the top ten
GO categories identified in this analysis and lists the top 25
differentially expressed genes within each of the top GO
categories.
Overall, GO category analysis of thymus tissue transcriptome
revealed down-regulation of important processes in thymocyte
development and up-regulation of inflammatory and wound
healing responses. Taken together, these results suggested that
intrathymic gene regulation can directly contribute to inflamma-
tion and thymic atrophy induced by systemic endotoxin challenge.
Below are categorized descriptions of the significant intrathymic
gene expression changes induced by systemic endotoxin challenge.
GO Analysis of Intrathymic Genes Involved in
Lymphocyte Activation and Thymocyte Development. As
predicted, steady state mRNA levels of many factors important for
thymopoiesis were down-regulated with endotoxin stress. Several
transcription factors were down-regulated, including Bcl11b, Rorc,
and Runx1. B-cell CLL/lymphoma 11B (Bcl11b) is a transcription
factor necessary for DP thymocyte development [15,16], RAR-
related orphan receptor C (Rorc) is a transcription factor for Th17
cells [17], and runt-related transcription factor 1 (Runx1)i sa
transcription factor necessary for proper thymocyte development
[18]. Several genes involved in VDJ recombination were also
down-regulated, including Dclre1c, Lig4, Rag1, and Rag2 (Table 3).
Intrathymc Stress Pathways
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thymocyte differentiation were decreased, including Adam17, Cd4,
Cd8, Cd27, Hells, Lat, Lck, Ppp3cb, Slamf1, and Stat5a (Table 3).
Adam17 is a lymphocyte extrinsic factor that is essential for normal
DN to DP transition during thymopoiesis [16]. Cd27 is up-regulated
at the DN III to DN IV transition, is further up-regulated upon pre-
TCR signaling, and contributes to thymocyte development [19].
Helicase Lymphoid Specific (Hells) is involved in chromatin
remodeling and transcriptional regulation, and is normally highly
expressed in the thymus, functioning to promote differentiation,
survival, and/or expansion of thymocytes at the transition from the
DN to the DP developmental stage [20]. Linker for activation of T
cells (Lat), signaling lymphocyte activation molecule family member
(Slamf1) and leukocyte-specific protein tyrosine kinase (Lck), are all
important in T cell activation [21,22]. Calcineurin (Ppp3cb)i s
required for positive selection and contributes to a developmental
period of ERK hypersensitivity, allowing very weak signals to
induce positive selection [23]. STAT5 plays a major role in IL-7-
mediated T cell development [24]. Interestingly, while Stat5 is
down-regulated, IL-7R is up-regulated in response to endotoxemia.
Otherup-regulatedgenesofnote includeCasitas B celllymphomab
(Cblb), which negatively regulates T cell antigen receptor (TCR)
signaling and is important for MHC-dependent CD4 and CD8
thymocyte development [25], and the anti-apoptotic proteins
PRKC, apoptosis, WT1, regulator (Pawr), which down-regulate
the anti-apoptotic protein Bcl2 [26] (Table 3).
GO Analysis of Intrathymic Genes Involved in Inflam-
mation. Many of the top intrathymic genes identified in the
biological regulation GO category (GO:0065007) are involved in tissue
inflammation (Table 3). Adamts1, an extracellular metalloproteinase
that promotes inflammation [27], was significantly increased.
CCAAT/enhancer binding protein (C/EBP), delta (Cebpd), an
important transcription factor for pro-inflammatory cytokine
production in a TLR/MyD88-dependent pathway in macrophages
[22] was also increased. Factors involved in the coagulation pathway
were up-regulated, including tissue factor (F3), and thrombospondin 1
(Thbs1). Of note, complement factor B (Ctb)a n dc o n n e c t i v et i s s u e
growth factor (Ctgf) were up-regulated.
Table 1. Endotoxin-induced peak cytokine levels in mice
(n=5).
Treatment
Cytokine Peak Hr
a Saline LPS p-value
TNF-a 13 7 2 6371 59,200615,9 0.0000349
IL-3 2 3.1064.28 18.6612.9 0.0338
IL-4 2 1.0160.372 1.7560.667 0.0636
IL-10 2 20.1622.4 5726376 0.0113
IL-13 2 2.0464.56 72.1621.8 0.000110
MCP-1 2 0.78061.74 39,900619,800 0.00309
MIP-1b 2 7.8964.88 36,80068,000 0.0000134
IL-2 4 0.02260.05 16.468.50 0.00259
IL-12p40 4 193662.9 24,00065,770 0.0000155
IL-12p70 4 23.1615.4 7266217 0.0000889
KC 4 7.8362.09 58,100634,800 0.00574
GM-CSF 4 0.52661.18 99.8615.3 0.000000515
MIP-1a 4 12.0626.8 23,40062,320 0.0000000162
Rantes 4 121647.2 8,07062,820 0.000234
IL-1a 6 73.066.89 274697.5 0.00174
IL-1b 6 73.6660.1 386681.5 0.000126
IL-5 6 18.1623.1 8436573 0.0123
IL-6 6 77.16164 14,90066,080 0.000622
IL-9 6 34.7612.8 72.7637.4 0.0643
IL-17 6 36.7679.6 4936247 0.00439
Eotaxin 6 1316257 9,91063,860 0.000478
G-CSF 6 18.9618.4 16,100619,900 0.155
IFN-c 6 3.4563.29 80.2646.8 0.00638
aPeak Hr: time of cytokine peak level post-treatment (in hours).
doi:10.1371/journal.pone.0017940.t001
Figure 1. Endotoxin-induced acute thymic atrophy. Female mice were administered either saline or E. coli LPS. (A) Thymus weight, (B) Total
number of thymocytes, (C) mTREC/mg thymus, (D) Absolute number of DP thymocytes. Representative flow cytometry plots of thymocyte
phenotype were determined at (E) one and (F) three days post treatment. (G) Representative hematoxylin and eosin staining of thymus tissue four
days post LPS challenge. *p,0.05 compared to saline-treated controls (n=5).
doi:10.1371/journal.pone.0017940.g001
Table 2. Endotoxin-induced intrathymic cytokine gene
expression.
Probeset ID Cytokine Fold Change Adjusted p-value
a
1419607_at TNF-a 2.6 0.0071
1450566_at IL-3 1.1 0.4082
1449864_at IL-4 21.1 0.7036
1450330_at IL-10 5.4 0.0025
1420802_at IL-13 1.2 0.2939
1420380_at MCP-1 (CCL2) 9.8 0.0024
1421578_at MIP-1b (CCL4) 5.9 0.0020
1449990_at IL-2 1.2 0.2301
1419530_at IL-12p40 2.0 0.0282
1449497_at IL-12p40 1.6 0.0980
1425454_a_at IL-12p35 1.0 0.8441
1419209_at KC (CXCL1) 71.7 0.0012
1457644_s_at KC (CXCL1) 26.0 0.0017
1441855_x_at KC (CXCL1) 3.8 0.0099
1427429_at GM-CSF (Csf2) 1.8 0.0160
1419561_at MIP-1a (CCL3) 57.0 0.0012
1418126_at Rantes (CCL5) 11.8 0.0046
1421473_at IL-1a 4.4 0.0096
1449399_a_at IL-1b 3.5 0.0030
1450550_at IL-5 1.3 0.1738
1450297_at IL-6 37.5 0.0018
1450565_at IL-9 1.1 0.3694
1421672_at IL-17 1.7 0.0164
1417789_at Eotaxin (CCL11) 1.6 0.0334
1419427_at G-CSF (Csf3) 24.7 0.0028
1425947_at IFN-c 1.1 0.5898
ap-values adjusted using Benjamini-Hochberg false discovery rate correction.
doi:10.1371/journal.pone.0017940.t002
Intrathymc Stress Pathways
PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e17940Important factors involved in pro-inflammatory cytokine cascades
were also increased (GO:0006955, GO:0006950), including the pro-
inflammatory cytokine IL-6 and the receptor for the IL-6 cytokine
family member oncostatin M (Osm). Many chemokines were up-
regulated in the thymus after endotoxin stress and were categorized in
gene ontologies of immune response and response to stress. These
included monocyte chemotactic protein (MCP)-5 (CCL12), MCP-1
(CCL2), macrophage inflammatory protein (MIP)-1 (CCL3), Regulat-
ed Upon Activation, Normal T-cell Expressed and Secreted
(RANTES/CCL5), MIP-1 delta (CCL9), granulocyte colony stimu-
lating factor 3(G-CSF/Csf3), KC (CXCL1), IP-10 (CXCL10), B
lymphocyte chemo-attractant (BLC/CXCL13), MIP-2a (CXCL2),
epithelial-derived neutrophil-activating peptide 78 (ENA-78/CXCL5),
monokine induced by gamma interferon (MIG/CXCL9). Interesting-
ly, Cd14, a co-receptor for TLR4, and cytotoxic T-lymphocyte-
associated protein 4 (Ctla4) were also up-regulated in response to
endotoxin stress in the thymus (Table 3) suggesting active TLR
responses and negative regulation of thymocyte signaling.
GO Analysis of Intrathymic Anti-Inflammatory Genes.
Moreover, factors associated with anti-inflammatory properties
were also induced by endotoxemia. Endotoxin challenge induced
metallothionein 1 and 2 (Mt1, Mt2), which play anti-inflammatory
roles in protection against heavy metal toxicity and scavenging of
free radicals [28]. Additional factors up-regulated include tissue
inhibitor of metalloproteinase 1 (Timp1) and orosomucoid 1
(Orm1). Orosomucoid 1 has been shown to stimulate fibroblast
proliferation and contribute to the process of wound healing [29].
Pathway Analysis of Endotoxin-Induced Intrathymic Gene
Expression
To further understand how differentially expressed genes may
interact to impact intrathymic pathways, significantly modulated
Table 3. Significant differentially expressed genes overrepresented in the gene ontology.
Gene ontology category p-value
a #/GO size
b Top 25 fold changes per GO category
c
% genes
change
d
Mean
FC
e
GO:0001775 2.51610
211 123/201 Bcl11b, Bcl3, Cblb, Ccnd3, Cd274, Cd8a, Crip3, Dclre1c, Fgg 41.5% up 2.25
Cell activation Foxp1, Gadd45g, Gna13, Hells, Il10, Lat, Lig4, Msh6, Pawr, 58.5% down 22.70
Pknox1, Rab27a, Rag1, Rag2, Rorc, Slamf1, Sp3
GO:0051301 7.79610
210 131/225 Aurkb, Birc5, Bub1, Ccne2, Ccnf, Cdc27, Cdc2a, Cdc6, Cdc7, 11.5% up 2.17
Cell division Cdca7, Fam33a, Fbxo5, Hells, Kif11, Kntc1, Lig4, Mcm5, 88.5% down 22.82
Ncapg2, Nek6, Nuf2, Sept4, Smc2, Spc25, Ube2c, Zbtb16
GO:0046649 1.51610
29 101/165 Adam17, Bcl11b, Bcl3, Cblb, Ccnd3, Cd274, Cd8a, Crip3, 35.6% up 2.22
Lymphocyte activation Dclre1c, Exo1, Fcgr2b, Foxp1, Gadd45g, Hells, Il10, Lig4, 64.3% down 22.74
Msh6, Pawr, Pknox1, Rab27a, Rag1, Rag2, Rorc, Slamf1, Sp3
GO:0000278 6.19610
29 138/245 Anln, Aurkb, Birc5, Bub1, Ccnf, Cdc27, Cdc2a, Cdc6, Cenpe, 16.7% up 2.33
Mitotic cell cycle Fam33a, Fbxo5,F o x g 1 ,Hells, Kif11, Kntc1, Ncapg2, Nek6, 83.3% down 22.68
Nuf2, Nusap1, Rhou, Slfn1, Smc2, Spc25, Stmn1, Ube2c
GO:0065007 7.48610
29 2109/5114 Adamts1, Aldh1a1, Cdca7, Cebpd, Cfb, Ctgf, Cyr61, 49.7% up 2.63
Biological regulation F3, Ifi204, Igfbp3, Iigp1, Il6, Lox, Mt1, Mt2, Orm1, Osmr, 50.3% down 22.30
Pdk4, Pth, Ptx3, Ramp3, Rorc, Sh2d1a, Thbs1, Timp1
GO:0006955 1.23610
28 119/208 BE136769, Ccl12, Ccl2, Ccl3, Ccl5, Ccl7, Ccl9, Cd14, Cd300lf, 74.8% up 6.85
Immune response Cd8b1, Clec4e, Csf3, Ctla4, Cxcl1, Cxcl10, Cxcl13, Cxcl2, 25.2% down 22.77
Cxcl5, Cxcl9, Gbp2, Gbp3, Lilrb4, Ptx3, Rsad2, Serpina3g
GO:0006950 5.06610
28 453/979 Ccl12, Ccl2, Ccl3, Ccl5, Cd14, Cfb, Cxcl1, Cxcl10, Cxcl13, 55.8% up 4.81
Response to stress Cxcl2, Cxcl5, Cxcl9, Defb1, Esco2, F3, Ifi204, Il6, Mx1, Orm1, 44.2% down 22.41
Rsad2, Saa1, Saa3, Serpina3n, Sh2d1a,T h b s 1
GO:0002521 4.07610
27 72/118 Ada, Adam17, Bcl11b, Bcl3, Cd24a, Cd27, Cd4, Cd8a, Dclre1c, 25.0% up 4.22
Leukocyte differentiation Foxp1, Gadd45g, Hells, Il6, Il7r, Lck, Lig4, Pknox1, Ppp3cb, 75.0% down 22.88
Ptprc, Rag1, Rag2, Rorc, Sash3, Satb1, Stat5a
GO:0048534 4.81610
27 155/296 Ada, Bcl11b, Bcl3, Cd27, Cd300lf, Cd4, Cd8a, Csf3, Cxcl13, 41.9% up 3.89
Hematop./lymph. organ devel. Epas1, Gadd45g, Hells, Il6, Lck, Lig4, Pknox1, Plscr1, Rag1, 58.1% down 22.18
Rag2, Rorc, Sod2, Sp3, Stap1, Timp1, Zbtb16
GO:0002376 5.19610
27 137/261 Bcl11b, Bcl2a1a, Ccnb2, Ccnd3, Crip3, Epas1, Hells, Hmgb1, 46.7% up 2.69
Immune system process Ifi30, Orm1, Pknox1, Plscr1, Rag1, Rag2, Rorc, Runx1, S100a9, 53.3% down 22.50
Selp, Slamf1, Sod2, Sp3, Stap1, Tapbp, Timp1, Zbtb16
aOverrepresented GO p-value determined by hypergeometric test.
bNumber (#) of individual significant genes present in GO category out of number possible in defined category (GO size).
cBased on absolute value of fold change. Down regulated genes in italics.
dPercentage of individual significant genes that grouped to GO category, showing both up- and down- regulated genes.
eMean fold changes of genes in each GO category, up- and down- regulated genes averaged separately.
doi:10.1371/journal.pone.0017940.t003
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Metacore pathway analysis software. Pathway analysis combines
mRNA expression levels, ontology categories, and defined
pathway information in order to predict cellular processes that
are involved in a response. This information was ranked by two
complementary methods following pathway analysis. Table 4
outlines the top pathways based on number of significant genes
identified within a canonical pathway, thus raising the overall
pathway significance (Top statistically significant pathways).
Table 5 lists pathways using the second method, based on the
standard deviation between differentially expressed genes in a
given pathway (Top differentially-affected pathways). In other
words, the latter analysis ranks pathways with larger absolute
differences between control (saline) and endotoxin (LPS) higher.
Top statistical categories included pathways involved in cytoskel-
etal and matrix remodeling, immune response, and cell cycle
pathways (Table 4). When identified pathways were sorted by the
degree of difference between saline control and endotoxin-challenged
animals (differentially-affected), the effect on the immune system, and
thymocyte functionspecifically, was more pronounced (Table5) as six
of the ten pathways refer specifically to immune-related responses.
The top differentially-affected pathway analysis revealed altered
expression of genes downstream of TLR3 and TLR4 following
endotoxin challenge, suggesting that endotoxin is directly influencing
thymus gene expression through toll-like receptor (TLR) binding
(Table 5 and Figure S1). This analysis demonstrated a direct impact
of LPS on thymus tissue itself, rather than LPS mediating thymic
involution solely as an indirect result of systemic responses (i.e.
systemic inflammation, HPA axis). The critical pathways identified in
this analysis, their component genes, and possible role in thymus
atrophy and recovery are described below.
Cytoskeletal and Extracellular Matrix Pathway
Analysis. Figure 2 indicates genes involved with cytoskeletal
rearrangement, extracellular matrix (ECM) interactions, and tissue
remodeling. This pathway is significantly activated in thymus tissue
stressed by endotoxin challenge as revealed by pathway analysis.
Several genes encoding members of the fibrinolytic (Serpine1/PAI1,
Serping1/C1 inhibitor, Plaur) and matrix metalloprotein (Mmp13)
proteolytic systems are activated in stressed thymus tissue [30,31].
Mmp13 expression was increased 27-fold in endotoxin challenged
thymus (Figure 2 and Table S1). In addition, increases in several
ECM gene mRNA levels are shown, including collagens (Col4a1,
Col4a2, Col1a2, Col1a1, Col4a4), laminin (Lamb1, Lamc1), and
fibronectin (Fn1). Genes for integrins that bind laminin (a3, b1,
b4), fibronectin (aV, b1), and collagen (b1) are also upregulated
(Itga3, Itgav, Itgb1, Itgb4) [32], demonstrating significant tissue
remodeling.
In addition to increases in mRNA levels of genes involved in
ECM pathways, several cytoskeletal genes are down-regulated
intrathymicaly following endotoxin challenge. Decreased expres-
sion levels in thymus tissue of Pak1, Vav1, Pik3r3, Pik3ca, Pik3r1,
Cdc42, Ptk2/Fak, and Pten can directly contribute to thymocyte
apoptosis through dysregulation of the actin cytoskeleton
[33,34,35,36,37]. Actin (Actb) and actin regulators Arp2/3 and
cofilin (Arpc4, Cfl1) also decreased significantly (Figure 2 and Table
S2). The observation that the top two significant pathways
involved genes for cytoskeleton and ECM remodeling (Table 4
and Figure S2) is consistent with the robust thymus morphological
changes observed four days following endotoxin challenge
(Figure 1). These intrathymic remodeling pathways can cooperate
with those regulating cell cycle and apoptosis to contribute to the
loss of thymopoiesis which is characteristic of acute thymic
atrophy. Indeed, multiple cell cycle pathways were determined to
be significant using Metacore pathway analysis (Table 4). Genes
that positively regulate cell cycle progression are down-regulated
in thymus following endotoxin challenge (Figure S3).
Pathway Analysis of Intrathymic Inflammatory Response
Genes. IL-6 transcription increases 37.5-foldin thymus tissue from
endotoxin challenged mice compared to saline controls (Tables 2 and
S1). Additional soluble factors with increased expression included
genes for Csf3/G-CSF (24.7 fold), CXCL5 (10.95 fold), CCL12
(10.57 fold), CCL7 (7.96 fold), CXCL3 (4.1 fold), IL-1b (3.5 fold), IL-
12b (1.98 fold), Csf2/GM-CSF (1.8 fold), IL-17 (1.73 fold), and
CCL20 (1.73 fold). Given that these analyses represented differential
gene expression from whole thymus tissue, these results confirmed
intrathymic production of inflammatory molecules. Furthermore,
several of these cytokines influence expression of IL-17 [38,39,40].
Pathway analysis identified the IL-17 signaling pathway as highly
significant (Figures 3 and S4), suggesting both intrathymic production
of, and response to, pro-inflammatory cytokines and chemokines.
Interestingly, the IL-17 signaling pathway contains several down-
regulated genes that overlap with other pathways. For example, Map
kinases 1, 11, 14, and Mapkkk 7 are also part of the cytoskeletal
remodeling pathway (Figure S2), and Sp1 is a transcription factor
important for cell cycle (Figure S3). In addition, the IL-1 signaling
pathway was highly significant (Figure S5) in this analysis. Taken
Table 4. Top statistically significant pathways
a.
Pathway name p-value
Cytoskeleton remodeling: Cytoskeleton remodeling 3.75610
215
Cytoskeleton remodeling: TGF, WNT and cytoskeletal remodeling 7.19610
215
Immune response: IL-17 signaling pathways 1.45610
213
Cell cycle: Chromosome condensation in prometaphase 1.15610
212
Immune response: CD28 signaling 1.07610
210
Immune response: Immunological synapse formation 1.11610
210
Cell adhesion: Chemokines and adhesion 1.67610
210
Cell cycle: Regulation of G1/S transition (part 2) 3.09610
210
Immune response: T cell receptor signaling pathway 4.36610
210
Cell cycle: Cell cycle (generic schema) 9.56610
210
aSignificance based on number of genes within defined pathways.
doi:10.1371/journal.pone.0017940.t004
Table 5. Top differentially-affected pathways
a.
Pathway name p-value
Immune response: TLR3 and TLR4 induce TICAM1 3.40610
203
Neurophysiological process: ACM regulation of nerve impulse 2.59610
203
Development: EGFR signaling pathway 1.47610
209
Immune response: CD28 signaling 1.07610
210
Immune response: Regulation of T cell function by CTLA-4 1.18610
208
Immune response: CD40 signaling 5.09610
208
Inhibitory action of Lipoxins and Resolvin E1 on neutrophil
functions
8.41610
202
Immune response: MIF-JAB1 signaling 8.24610
203
Ca(2+)-dependent NF-AT signaling in Cardiac Hypertrophy 2.02610
202
Muscle contraction: EDG5-mediated smooth muscle contraction 2.03610
202
aSignificance reflects absolute differences (by standard deviation) with respect
to saline vs. LPS.
doi:10.1371/journal.pone.0017940.t005
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inflammatory cytokines could directly influence remodeling and cell
cycle responses within thymus.
Pathway Analysis of Thymocyte Antigen Receptor
Signaling. Double positive thymocytes are the most severely
affected cell type in thymus, compared to thymic stroma, during
endotoxemia, which results in characteristic acute thymic atrophy
seen after LPS challenge (Figure 1). Thymocyte functional pathways
were therefore examined. Many of the top pathways within the
immune response group (Tables 4 and 5) are directly related to T cell
signaling, which is important for proper thymocyte development.
Pathway analysis of intrathymic gene expression suggested direct cell-
cell interactions could play an important role in thymocyte apoptosis
in addition to soluble mediators of inflammation. Several pathways
involving T cell receptor (TCR) signaling and thymocyte activation
were identified as significant by Metacore analysis. Figure 4 depicts a
reduction in mRNA levels of genes involved in the thymocyte
immunological synapse pathway following LPS challenge. Pathway
analysis also predicted a reduction in the TCR/CD28 signaling
pathway (Figure 5, Tables 4 and 5). Cd80, Cd86, Icam1,a n ds e v e r a l
H2-A and H2-E (MHC Class II) genes critical for antigen
presentation to thymocytes were up-regulated following endotoxin
challenge (Figures 4 and 5, Table S1). Interestingly, TCR alpha and
beta genes (Tcra,Tcrb-j),andmRNAforTcellsurfacemoleculesCD3
epsilon, CD4, CD28, CD2, and LFA-1 (Itgal, Itgb2) were significantly
lower in the atrophic thymus (Figures 4 and 5, Table S2). These
analyses suggested a mechanism for decreased TCR signaling which
may contribute to thymocyte apoptosis characteristic of atrophic
thymus tissue. Indeed, important signal transduction molecules Lck,
Lat, Zap70, Grb2, and PKCh, as well as down-stream modulators
such as calmodulin (Calm1, 2, and 3)a n dN F A T( Nfatc1 and Nfatc3)
[41,42], were all down-regulated (Figure 5 and Table S2). The
decreased expression of immune synapse integrin LFA-1 (Itgal, Itgb2)
[43] and key cytoskeletal regulators (Vav1, Wasl, Was, Cdc42, Rac2)
supported animportant role for adhesion and cytoskeletalremodeling
in TCR signaling [44,45].
While an abundance of critical TCR signaling-related genes
were down-regulated in thymus following endotoxic stress, CTLA-
4 was significantly up-regulated (Table S1). The regulation of T
cell function by CTLA-4 pathway (Figure 5) was highly significant
in this analysis (Table 5). Since CTLA-4 is known to negatively
regulate T cell activation in the periphery [46], increased
expression in stressed thymus tissue could indicate an active
suppression of thymocyte activation leading to apoptosis and
subsequent thymic atrophy [47,48].
Discussion
Intrathymic mechanisms driving acute thymus atrophy follow-
ing endotoxemia were investigated in a mouse model. Within
Figure 2. Cytoskeleton and matrix remodeling during acute thymic atrophy. The cytoskeleton remodeling pathway scored highest in
Metacore pathway analysis based on number of significant genes (p-value=3.75610
215). Red genes represent significant increases in mRNA levels
and blue genes represent significant decreases in mRNA levels in thymus tissue following LPS treatment. Mean fold changes are given. Green arrows
indicate positive influence and red T-bars indicate negative influence. Arrows may represent multiple steps. Plasma membrane is shown in gray. A
detailed version of the original Metacore pathway is found as Figure S2. A full legend of all GeneGo pathway map symbols is in Figure S9 or at http://
www.genego.com/pdf/MC_legend.pdf.
doi:10.1371/journal.pone.0017940.g002
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pro-inflammatory cytokine cascade which resulted in losses of
thymic cellularity, TCRa gene rearrangement, and DP thymocyte
distribution. These characteristic responses to endotoxic stress
culminated in significant remodeling of thymus architecture within
three to four days post treatment.
A phenotypic, histologic and transcriptome/pathway analysis of
murine thymic tissue during the early stages of endotoxemia-
induced involution was undertaken in this study to define
intrathymic mechanisms that drive this observed acute thymic
atrophy. These studies support the hypothesis that multiple key
intrathymic pathways are differentially activated during endotox-
emia-induced thymic involution and demonstrate for the first time
direct activation of thymus tissue by LPS through TLR signaling,
local thymus expression of inflammatory cytokines, inhibition of T
cell signaling, and induction of wound healing/tissue remodeling.
Whole murine thymus transcriptome analysis one day post
endotoxin challenge identified several intrathymic pathways to be
modulated during stress-induced acute thymic atrophy, suggesting
active involvement of thymic residents in thymopoietic and
morphological dysregulation. Findings presented identified up-
regulation of genes involved in inflammation and wound healing
and down-regulation of genes involved in cell cycle, immune
response, and thymocyte activation/signaling during early stages
of stress-induced thymic involution. Taken together, these
observations suggested that both systemic and direct intrathymic
responses to endotoxin challenge concurrently contribute to
thymic involution during endotoxemia. These findings are a
substantial advancement over current understanding of thymus
response to stress and may lead to the development of novel
therapeutic approaches to ameliorate immune deficiency associ-
ated with stress events.
Transcriptome analysis of whole thymus tissue undergoing
acute involution confirmed the active nature of thymus atrophy at
the cellular level. Down-regulation of many processes involved in
thymocyte proliferation and differentiation were observed, includ-
ing decreased cell activation and division, mitotic cell cycle
dysregulation, and decreased lymphocyte activation and differen-
tiation (Table 3). Important transcription factors (i.e. Bcl11b) and
factors necessary for lymphocyte development (i.e., Rag1, Rag2,
Figure 3. Modulation of IL-17 signaling during acute thymic atrophy. The IL-17 pathway ranked as the third most statistically significant
pathway (p-value=1.45610
213) using Metacore pathway analysis. This pathway includes genes for both secreted pro-inflammatory cytokines and
the intracellular response through IL-17R. Red genes represent significant increases in mRNA levels and blue genes represent significant decreasesi n
mRNA levels in thymus tissue following LPS treatment. Mean fold changes are given. Green arrows indicate positive influence. Arrows may represent
multiple steps. Plasma membrane is shown in gray. Nuclear membrane is shown as dotted line. A detailed version of the original Metacore pathway is
in Figure S4. A full legend of all GeneGo pathway map symbols is in Figure S9 or at http://www.genego.com/pdf/MC_legend.pdf.
doi:10.1371/journal.pone.0017940.g003
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were all down-regulated (Table S2). These data confirmed and
provide direct evidence for the rapid decrease in T cell
development that occurs following endotoxemia. These observa-
tions, however, did not indicate whether the mechanisms driving
thymic involution were mediated systemically or intrathymically.
Therefore, a complex expression and pathway analysis of genes
involved in thymus function and response to stress was undertaken
in this study.
A systemic pro-inflammatory cytokine cascade activated by
endotoxin-induced stress occurred within the first 24 hours of
endotoxemia (Table 1). These observations were consistent with
those reported in the literature [4,6]. There have been no reports
however regarding intrathymic production of pro-inflammatory
cytokines in response to endotoxin-induced stress. Herein is
reported the novel observation that thymus actively up-regulates
pro-inflammatory cytokine genes (Table 2). Many of the cytokines
up-regulated intrathymically were identical to those produced
systemically at the protein level (TNFa, IL-10, MCP-1, MIP-1b,
IL-12p40, KC, GM-CSF, MIP-1a, RANTES, IL-1a, IL-1b, IL-6,
IL-17, and Eotaxin). This intrathymic up-regulation of cytokine
mRNA, many of which are pro-inflammatory, suggested that cells
within the thymus itself are producing thymosuppressive factors
that likely contribute to thymic atrophy. Gene expression for
TNFa (Tnf), an important pro-inflammatory cytokine, was up-
regulated intrathymically (Table 2), and it has recently been shown
that chronic low-level over-expression of TNFa in mice leads to
thymic atrophy [49]. Moreover, intrathymic gene expression for
IL-6 was significantly up-regulated, which contributes to acute
thymic atrophy. Work from this laboratory has previously shown
that injection of IL-6, as well as IL-6 family members LIF and
OSM, actively induce acute thymic atrophy within three days
[50]. Interestingly, the receptor for OSM (Osmr) was also up-
regulated in response to endotoxemia (Table S1), suggesting that
OSM signaling has the potential to be up-regulated as well.
Intrathymic regulation of many chemokines was increased
(Tables 2, 3, and S1), providing further evidence of a substantial
intrathymic inflammatory response. A 23-fold increase in the
mRNA of TLR4 co-receptor, CD14, was also seen in these studies
(Table S1). Furthermore, TLR-signaling was the top differentially-
affected pathway in thymus of endotoxin-challenged mice (Table 5
and Figure S1), strongly suggesting a direct response of cells within
the thymus to endotoxin. Activation of a local inflammatory and
host response was further supported by the up-regulation of NF-
kB (Figure 5 and Table S1). NF-kB can be activated by TLR
signaling and by pro-inflammatory cytokines, such as IL-1 and
TNFa [51]; both of which were up-regulated intrathymically in
response to endotoxin stress. Taken together, these data support
the conclusions that thymus tissue directly responds to endotoxin
stress by actively up-regulating cytokine and chemokine gene
expression, and that these inflammatory mediators may contribute
intrathymically to acute thymic atrophy.
While inflammation alone can be damaging, it precedes
granulation tissue formation and cytoskeleton/ECM remodeling
necessary for wound healing [51]. Many significant changes were
detected in the cytoskeleton and ECM remodeling pathway
analysis of stressed-thymus tissue (Figure 2). These observations
are consistent with the down-stream robust morphological changes
Figure 4. Dysregulation of immunological synapse formation during acute thymic atrophy. The immune synapse pathway ranked sixth
in statistical significance (p-value=1.11610
210) using Metacore analysis. Positive regulators of immune synapse formation and function were
decreased following endotoxin stress in thymus. Red genes represent significant increases in mRNA levels and blue genes represent significant
decreases in mRNA levels in thymus tissue following LPS treatment. Mean fold changes are given. Green arrows indicate positive influence. Arrows
may represent multiple steps. Plasma membranes are shown in gray. A detailed version of the original Metacore pathway is in Figure S6. A full legend
of all GeneGo pathway map symbols is in Figure S9 or at http://www.genego.com/pdf/MC_legend.pdf.
doi:10.1371/journal.pone.0017940.g004
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Several gene expression changes involved in thymic architecture
remodeling likely contributed to the degradation of cortico-
medullary junctions observed following endotoxin stress; however,
many other gene changes suggested the potential for positive tissue
remodeling. Transcriptome analysis revealed up-regulation of
fibronectin, laminin, and collagen (Figure 2), important ECM
components [51]. Up-regulation of these molecules and pathways
may be a preparative process for subsequent tissue regeneration
and recovery, which has been reported for stress-induced acute
thymic atrophy [5].
Other factors that may contribute to thymus tissue recovery
include IL-7R and the anti-inflammatory cytokine IL-10. IL-7R
was up-regulated, which may indicate a compensatory mecha-
nism, as IL-7 signaling is necessary for thymocyte development
[52]. IL-10 was also upregulated and may be important for the
resolution of thymic inflammation. The anti-inflammatory activity
of IL-10 includes down-regulation of IL-1, IL-6, IL-12, TNFa,
and many inflammatory chemokines [53]. Increased thymus
transcription of these pro-inflammatory factors may become
down-stream targets of IL-10 during resolution of inflammation.
Taken together, the involvement of important growth factor
receptors and anti-inflammatory mediators, combined with
activation of intrathymic wound healing pathways suggested that
gene changes necessary for recovery from thymus atrophy are
activated upon the onset of involution.
A significant decrease was observed in TCR signaling genes, a
pathway necessary for productive thymocyte development [54].
The TCR/CD28 signaling pathway was significantly down-
regulated (Figure 5). CTLA-4 mRNA, however, significantly
increased following endotoxin challenge (Table S1). Since CTLA-
4 is known to negatively regulate T cell activation in the periphery
[46], increased expression in the thymus could indicate an active
suppression of thymocyte activation leading to apoptosis [47,48].
This role for CTLA-4 in thymocyte development, however,
remains unclear [55,56,57]. Cytoskeletal remodeling and adhesion
Figure 5. Decreased CD28 signaling and activated CTLA-4 pathways during acute thymic atrophy. The CD28 pathway ranked fifth in
significance and fourth by differential expression (p-value=1.07610
210) using Metacore pathway analysis. Pathway analysis also determined the
CTLA-4 pathway to be differentially affected (p-value=1.18610
28). CTLA-4, CD86 and CD80 mRNA levels were significantly increased while CD28 and
TCR signaling-related mRNA levels were decreased. Red genes represent significant increases in mRNA levels and blue genes represent significant
decreases in mRNA levels in thymus tissue following LPS treatment. Mean fold changes are given. Green arrows indicate positive influence and red T-
bars indicate negative influence. Arrows may represent multiple steps. Plasma membranes are shown in gray. Nuclear membrane is shown as dotted
line. A detailed version of the original Metacore pathways are in Figures S7 and S8. A full legend of all GeneGo pathway map symbols is in Figure S9
or at http://www.genego.com/pdf/MC_legend.pdf.
doi:10.1371/journal.pone.0017940.g005
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expression of immune synapse integrin LFA-1 (Itga1, Itgb2) [43]
and key cytoskeletal regulators (Vav1, Wasl, Was, Cdc42, Rac2)
correlated with the observed decrease in TCR signaling
machinery, confirming the interaction of cytoskeletal remodeling
and TCR signaling pathways (Table S1, Figures 4 and 5). These
observations demonstrated how many pathways overlap, with
dysregulation of one pathway potentially impacting another.
Data presented herein provide novel evidence that specific gene
expression changes are activated in thymus tissue during early
stages of stress-induced acute thymus atrophy. Many of these
reported gene changes confirmed the process of thymus atrophy,
including decreased thymocyte development, activation, and cell
cycle progression. These observations correlated with loss of
thymus cellularity and decreased thymopoiesis. There were several
gene changes, however, that indicated an active intrathymic
inflammatory response, in addition to the systemic inflammatory
response, and likely contributed to the overall destruction of
thymus tissue, induction of thymus atrophy, and loss of thymic
output. These observations support the emerging paradigm in
which active production of thymosuppressive cytokines/mediators
can induce acute thymic atrophy [50,58]. Therapies that target the
depression of intrathymic production of inflammatory factors hold
potential to protect the thymus against involution and limit tissue
destruction during the important inflammatory response to
harmful pathogens or agents. Moreover, it is speculated that early
up-regulation of genes involved in wound healing and matrix
remodeling in thymus may lay the ground work for thymus
recovery. Further investigation is needed to identify recovery
mechanisms that are activated at the onset of thymus involution
which could be manipulated to hasten recovery of thymus function
following stress events and accelerate immune reconstitution.
Additional studies are necessary to investigate the interesting
possibility that some of these genes may indicate regenerative
potential and be exploited for treatment of chronically involuted
thymus in the elderly. Taken together, transcriptome analysis of
thymus tissue during acute involution demonstrated that the
thymus itself is actively responding to stress and contributing with
intrathymic inflammatory and regenerative responses.
Materials and Methods
Ethics Statement
All mice were housed in a specific pathogen-free environment
with 12-hour light/dark cycles at 20–25uC in accordance with
Duke University IACUC-approved animal protocols (A152-08-
05). All efforts were made to minimize pain and suffering. No
human samples were used in this study.
Animals, Treatments, and Reagents
Female C57BL/6 mice (8–10 weeks old) were purchased from
Charles River. Escherichia coli-derived lipopolysaccharide (LPS) was
purchased from Sigma-Aldrich (L-2880; St. Louis, MO) and
reconstituted at 1 mg/mL in PBS. LPS (100 ug) or saline were
administered by intraperitoneal injection. Replicate groups of
animals were bled at various time points to determine serum
cytokine levels prior to euthanasia for tissue harvest (30 minutes to
7 days post treatment). Serum was isolated by centrifugation for
10 min at 3,0006g and transferred to a 96-well round-bottom
culture plate and stored at 220uC until thawed for analysis. Mice
were euthanized by CO2 administration for 10 minutes followed
by cervical dislocation. Thymus tissue was removed and weighed.
Organs were divided into two halves; one half was placed in a 60-
mm tissue culture dish containing 3 mL RPMI 1640 (Invitrogen;
Grand Island, NY) with 5% fetal calf serum (tissue medium) and
one half was placed into a 1.8 mL cryotube and snap frozen in an
ethanol/dry ice bath.
Cell Isolation and Flow Cytometry
Thymus tissue was teased to a single-cell suspension through a
70 mm cell strainer (BD Labware; Franklin Lakes, NJ) in tissue
medium. Thymocytes were centrifuged at 1,500 rpm for 5 minutes
and resuspended in 2–5 mL tissue medium for cell counts and
immunofluorescent staining. Cell counts were performed in triplicate
on a Coulter Z1 Dual threshold cell counter (Coulter; Hialeah, FL)
and mean recorded. Total thymus cell counts were extrapolated
based on percentage weight of the teased portion ofthymus relativeto
whole thymus weight. Immunofluorescence staining was performed
with anti-mouse directly-conjugated monoclonal antibodies: anti-
CD3 FITC, anti-CD4 PE, anti-CD8 PerCP-Cy5.5 (BD Biosciences).
Cell suspensions were added to PBS Wash (16 PBS+1% bovine
serum albumin+0.1% sodium azide) and diluted antibody, incubated
for 45 minutes at 4uC, washed and resuspended in PBS Wash
containing 0.4% (w/v) paraformaldehyde. Immunophenotype data
were acquired on a BD LSRII or BD FACS Canto and analyzed with
FlowJo software (TreeStar, Inc.; DHVI Research Flow Cytometry
Shared Resource Facility, Durham, NC).
Quantitative PCR for Mouse Signal Joint TCR Delta
Excision Circles (sjTREC)
Total genomic DNA from thymus tissue was extracted using
Trizol Reagent (Invitrogen) per manufacturer’s protocol. DNA
was quantified by spectrophotometry (260 nm). Molecules of
mouse TCRD sjTREC were quantified by real-time PCR using a
standard curve of known number of molecules of mouse (m)
TREC, specific primers and fluorescent probe as previously
described (21). Briefly, an excess of forward and reverse DNA
primers for the mTREC sequence and DNA probe conjugated to
a fluorescent dye was added to genomic thymus DNA. Real-time
PCR using BioRad iCycler IQ allowed detection and quantifica-
tion of mTREC numbers per 1 mg DNA in each sample. Numbers
of mTREC were normalized to reflect levels per mg thymus tissue.
Hematoxylin and Eosin Staining of Thymus Tissue
Thymus tissue was removed from mice as described above and
embedded in O.C.T. Tissue Tek medium (Sakura). Tissue was
frozen in a Histo Bath (Shandon/Lipshaw) and stored at 280uC.
Tissue sections (5 mm) were cut on a Cryocut 1800 (Leica
Biosystems), placed on Superfrost Plus microslides (VWR
International) and stored at 280uC until staining. Sections were
fixed for 2 minutes in ice cold acetone (220uC) and then air dried.
Slides were stained with hematoxylin and counterstained with
eosin. Analysis was performed with a Nikon Eclipse TE2000-E
and NIS Elements 2.0 software (Nikon Instruments Inc) in the
DHVI Light Microscopy Shared Resource Facility, Durham, NC.
Bead-based Multiplex Cytokine Analysis
Serum cytokine levels were determined by multiplex bead-based
assays using BioPlex mouse cytokine/chemokine kits according to
the manufacturer’s protocol (BioRad; Hercules, CA). All bead
assay samples were quantified on the BioPlex protein array reader
(BioRad) in the DHVI Immune Reconstitution and Biomarker
Shared Resource Facility (Durham, NC).
RNA Extraction and Microarray
Total RNA from snap frozen thymus tissue was extracted using
Trizol Reagent (Invitrogen) per manufacturer’s protocol and
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using an RNeasy Mini Kit per manufacturer’s protocol (Qiagen).
RNA microarrays were performed by the Duke Microarray
Facility in the Duke Institute for Genome Sciences & Policy
Department (Durham, NC). Briefly, RNA quality was assessed on
an Agilent 2100 Bioanalyzer (Agilent Technologies). Hybridization
of total RNA to Affymetrix Mouse genome 430.2 oligonucleotide
arrays was performed according to Duke Microarray Facility
protocols. Control and LPS treatment data represent experimental
replicates.
Microarray Data Analysis and Statistics
Microarray data analysis was performed using Bioconductor
packages under the R statistical language environment [59,60].
Scanned microarray CEL output files were checked for quality
assurance and raw signal intensities were RMA normalized using
the affy package [61]. For differential gene expression analysis, the
limma package [62] was used for linear model fitting and
empirical Bayes methods to determine statistical significance.
These genes were then clustered into categories based on over
representation of gene ontology terms by hypergeometric test
using GOstats package [63]. More detailed procedures can be
found at the Bioconductor website (http://www.bioconductor.
org). Pathway analysis on statistically significant genes was
performed using MetaCore software by GeneGo (St. Joseph,
MI). Figures in the text are adaptations based on those created by
the MetaCore software. The original MetaCore figures are
included in supporting supplemental figures. For animal studies,
two-tailed Student’s t test was employed to compare the means
between data sets.
Supporting Information
Figure S1 Activated TLR3 and TLR4 signaling during
acute thymic atrophy. TLR3/TLR4 pathway was the most
differentially affected pathway (p=3.40610
23) when comparing
saline-treated to LPS-treated mice. Red data thermometers reflect
relative mRNA transcript levels in thymus tissue for control and
LPS challenge. EC: extracellular; PM: plasma membrane; IC:
intracellular; NU: nuclear. A full legend of all GeneGo pathway
map symbols is in Figure S9 or at http://www.genego.com/pdf/
MC_legend.pdf.
(TIFF)
Figure S2 Increased cytoskeleton remodeling during
acute thymic atrophy. The cytoskeleton remodeling pathway
scored highest in Metacore pathway analysis based on number of
significant genes (p-value=3.75610
215). Data thermometers
reflect relative fold change in mRNA steady-state levels in thymus
tissue following LPS challenge. Red thermometers represent
significantly increased mRNA levels and blue thermometers
represent significantly decreased mRNA levels. EC: extracellular;
PM: plasma membrane; IC: intracellular; NU: nuclear. A full
legend of all GeneGo pathway map symbols is in Figure S9 or at
http://www.genego.com/pdf/MC_legend.pdf.
(TIFF)
Figure S3 Down-regulation of G1/S cell cycle transi-
tion. The cell cycle transition pathway revealed many genes
involved with cell cycle progression to be significantly down-
regulated (p=3.09610
210) in thymus tissue following endotoxin
challenge [64]. Data thermometers reflect relative fold change in
gene transcript levels in thymus tissue following LPS challenge.
Red thermometers represent significantly increased mRNA levels
and blue thermometers represent significantly decreased mRNA
levels. EC: extracellular; PM: plasma membrane; IC: intracellular;
NU: nuclear. A full legend of all GeneGo pathway map symbols is
in Figure S9 or at http://www.genego.com/pdf/MC_legend.pdf.
(TIFF)
Figure S4 Modulation of IL-17 signaling during acute
thymic atrophy. The IL-17 pathway ranked as the third most
statistically significant pathway (p-value=1.45610
213) using
Metacore pathway analysis. This pathway includes genes for both
secreted pro-inflammatory cytokines and the intracellular response
through IL-17R. Data thermometers reflect relative fold change in
steady-state mRNA level in thymus tissue following LPS challenge.
Red thermometers represent significantly increased mRNA levels
and blue thermometers represent significantly decreased mRNA
levels. EC: extracellular; PM: plasma membrane; IC: intracellular;
NU: nuclear. A full legend of all GeneGo pathway map symbols is
in Figure S9 or at http://www.genego.com/pdf/MC_legend.pdf.
(TIFF)
Figure S5 Modulation of IL-1 signaling pathway during
acute thymic atrophy. Differential gene expression of members
of the IL-1 receptor signaling pathway (p=3.5610
29). Data
thermometers reflect relative fold change in gene transcript levels
in thymus tissue following LPS challenge. Red thermometers
represent significantly increased mRNA levels and blue thermom-
eters represent significantly decreased mRNA levels. EC: extra-
cellular; PM: plasma membrane; IC: intracellular; NU: nuclear. A
full legend of all GeneGo pathway map symbols is in Figure S9 or
at http://www.genego.com/pdf/MC_legend.pdf.
(TIFF)
Figure S6 Dysregulation of immunological synapse
formation during acute thymic atrophy. The immune
synapse pathway ranked sixth in statistical significance (p-
value=1.11610
210) using Metacore analysis. Positive regulators
of immune synapse formation and function were decreased
following endotoxin stress in thymus. Data thermometers reflect
relative fold change in gene transcript levels in thymus tissue
following LPS challenge. Red thermometers represent significantly
increased mRNA levels and blue thermometers represent
significantly decreased mRNA levels. EC: extracellular; PM:
plasma membrane; IC: intracellular; NU: nuclear. A full legend
of all GeneGo pathway map symbols is in Figure S9 or at http://
www.genego.com/pdf/MC_legend.pdf.
(TIFF)
Figure S7 Decreased CD28 signaling during acute
thymic atrophy. The CD28 pathway ranked fifth in significance
and fourth by differential expression (p-value=1.07610
210) using
Metacore pathway analysis. Genes involved in TCR signaling and
thymocyte stimulation via the CD28 pathway are down-regulated
in thymus tissue from endotoxin challenged mice. Data thermom-
eters reflect relative fold change in gene transcript levels in thymus
tissue following LPS challenge. Red thermometers represent
significantly increased mRNA levels and blue thermometers
represent significantly decreased mRNA levels. EC: extracellular;
PM: plasma membrane; IC: intracellular; NU: nuclear. A full
legend of all GeneGo pathway map symbols is in Figure S9 or at
http://www.genego.com/pdf/MC_legend.pdf.
(TIFF)
Figure S8 Activated CTLA-4/CD80/CD86 pathway dur-
ing acute thymic atrophy. Pathway analysis of significant
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affected (p-value=1.18610
28). CTLA-4, CD86 and CD80 were
increased while CD28 and TCR-related mRNA levels were
decreased. Data thermometers reflect relative fold change in gene
transcript levels in thymus tissue following LPS challenge. Red
thermometers represent significantly increased mRNA levels and
blue thermometers represent significantly decreased mRNA levels.
EC: extracellular; PM: plasma membrane; IC: intracellular; NU:
nuclear. A full legend of all GeneGo pathway map symbols is in
Figure S9 or at http://www.genego.com/pdf/MC_legend.pdf.
(TIFF)
Figure S9 GeneGo pathway map legend. Available for
download at http://www.genego.com/pdf/MC_legend.pdf.
(PDF)
Table S1 Significant gene increases within thymus
tissue. Following normalization, microarray data was tested
using the limma Bioconductor package for linear model fitting and
an empirical Bayes method of determination of statistical
significance. After false discovery rate was corrected using the
Benjamin-Hochberg method, significant gene expression changes
(corrected p,0.05) were sorted. Shown are all genes with a mean
expression level above 5 and fold changes greater than 1.4.
(XLS)
Table S2 Significant gene decreases within thymus
tissue. Following normalization, microarray data was tested
using the limma Bioconductor package for linear model fitting and
an empirical Bayes method of determination of statistical
significance. After false discovery rate was corrected using the
Benjamin-Hochberg method, significant gene expression changes
(corrected p,0.05) were sorted. Shown are all genes that
decreased more than 1.4 fold. Genes with a mean expression
level below 5 are not shown.
(XLS)
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